New guidance from the UK Medicines and Healthcare products Regulatory Agency sets out how pharmacovigilance requirements will change from 1 January 2025, when the post-Brexit “Windsor Framework” for easing the movement of goods between Great Britain and Northern Ireland comes into effect.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?